J-GLOBAL ID：201801014965951201
Update date: Aug. 30, 2024
Mukumoto Nobutaka
Mukumoto Nobutaka
Research field (1)：
Radiology
Research theme for competitive and other funds (5)：
2022 - 2026 Development of basic technology for next-generation MR-guided radiation therapy based on biofunctional dynamic information
2020 - 2023 Development of margin-less adaptive radiotherapy for patient organ deformations
2018 - 2023 国際医学物理ネットワークを軸とした放射線治療における先端技術の創出と普及
2018 - 2020 Development of high-robust four-dimensional radiotherapy system for respiration-induced tumor motion
2015 - 2018 Development of a novel prediction model for the dynamic tumor tracking toward the high-accurate four-dimensional image-guided radiotherapy
Papers (90)：
Hiraku Iramina, Masato Tsuneda, Hiroyuki Okamoto, Noriyuki Kadoya, Nobutaka Mukumoto, Masahiko Toyota, Junichi Fukunaga, Yukio Fujita, Naoki Tohyama, Hiroshi Onishi, et al. Multi-institutional questionnaire-based survey on online adaptive radiotherapy performed using commercial systems in Japan in 2023. Radiological physics and technology. 2024
N. Kishi, Y. Matsuo, T. Ono, N. Matsushita, N. Mukumoto, Y. Tsuruta, M. Sasaki, T. Fujimoto, M. Nakamura, T. Mizowaki. EP08.02-32 Optimal Planning Target Volume Margins for Spirometer-Based DIBH Radiotherapy for Lung Cancer. Journal of Thoracic Oncology. 2023. 18. 11. S583-S584
Satoshi Kito, Nobutaka Mukumoto, Mitsuhiro Nakamura, Hiroaki Tanabe, Katsuyuki Karasawa, Masaki Kokubo, Takashi Sakamoto, Yusuke Iizuka, Michio Yoshimura, Yukinori Matsuo, et al. Population-based asymmetric margins for moving targets in real-time tumor tracking. Medical physics. 2023
Y. Ono, Y. Lizuka, K. Nakamura, T. Ono, N. Mukumoto, M. Yoshimura, Y. Matsuo, T. Mizowaki. PD-0974 Initial report of prospective feasibility study for modified track Dynamic WaveArc therapy. Radiotherapy and Oncology. 2023. 182. S822-S823
Mai Sakagami, Haruo Inokuchi, Nobutaka Mukumoto, Hiroshige Itoyama, Nobunari Hamaura, Mutsumi Yamagishi, Naoki Mukumoto, Shogo Matsuda, Daijiro Kabata, Keiko Shibuya. Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer. RADIATION ONCOLOGY. 2023. 18. 1
K. Fujii, N. Mukumoto, K. Nakamura, M. Nakamura, K. Takayama, T. Mizowaki. Evaluation of Knowledge-Based Versus Manual Treatment Planning of Whole-Pelvic Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Node-Positive Prostate Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017. 99. 2. E660-E661
M. Uto, T. Mizowaki, K. Ogura, K. Nakamura, N. Mukumoto, K. Yokota, Y. Miyabe, H. Hirashima, M. Hiraoka. Reduction of Hippocampal Doses for Craniopharyngiomas Using Volumetric Modulated Wave Arc Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2016. 96. 2. E71-E71
